aTyr Pharma, Inc.
US ˙ NasdaqCM ˙ US0021202025

SecurityATYR / aTyr Pharma, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership54,026 shares
Latest Disclosed Value $ 42,961
Wolverine Trading, Llc ownership in ATYR / aTyr Pharma, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 54,026 shares of aTyr Pharma, Inc. (US:ATYR) valued at $38,974 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 0 shares of aTyr Pharma, Inc.. The current value of the position is $27,018 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (ATYR) in the form of stock options. The firm currently holds call options representing 205,100 of underlying shares valued at $163,096 USD and put options representing 138,900 of underlying shares valued at $110,453 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ATYR / aTyr Pharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F ATYR PHARMA COM NEW 002120202 54,026 54,026 43 0.0000
2025-08-18 2025-06-30 13F ATYR PHARMA COM NEW 002120202 0 -45,327 -100.00 0 -100.00
2025-05-15 2025-03-31 13F ATYR PHARMA COM NEW 002120202 45,327 26,474 140.42 142 113.64 0.0002
2025-02-14 2024-12-31 13F ATYR PHARMA COM NEW 002120202 18,853 18,853 66 0.0001
2023-05-15 2023-03-31 13F ATYR PHARMA COM NEW 002120202 0 -22,685 -100.00 0 -100.00
2023-02-14 2022-12-31 13F ATYR PHARMA COM NEW 002120202 22,685 22,685 50 0.0001
2022-08-15 2022-06-30 13F ATYR PHARMA COM NEW 002120202 0 -22,089 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ATYR PHARMA COM NEW 002120202 22,089 22,089 120 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ATYR PHARMA COM NEW Call 205,100 163 n/a n/a n/a
2025-08-18 2025-06-30 13F ATYR PHARMA COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ATYR PHARMA COM NEW Call 58,500 183 n/a n/a n/a
2024-02-14 2023-12-31 13F ATYR PHARMA COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F ATYR PHARMA COM NEW Call 10,700 17 n/a n/a n/a
2022-02-14 2021-12-31 13F ATYR PHARMA COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ATYR PHARMA COM NEW Call 42,900 381 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ATYR PHARMA COM NEW Put 138,900 110 n/a n/a n/a
2025-08-18 2025-06-30 13F ATYR PHARMA COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ATYR PHARMA COM NEW Put 17,500 31.58 55 17.39 n/a n/a n/a
2025-02-14 2024-12-31 13F ATYR PHARMA COM NEW Put 13,300 47 n/a n/a n/a
2023-05-15 2023-03-31 13F ATYR PHARMA COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F ATYR PHARMA COM NEW Put 33,300 73 n/a n/a n/a
2022-08-15 2022-06-30 13F ATYR PHARMA COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F ATYR PHARMA COM NEW Put 35,700 195 n/a n/a n/a
2022-02-14 2021-12-31 13F ATYR PHARMA COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F ATYR PHARMA COM NEW Put 18,000 160 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.